Blue Goose Capital

Blue Goose Capital is investing in biopharma, data and device companies, seed stage to Series B in the United States and Spain. Historically, Blue Goose Capital has invested in seed-stage biotechnology and healthcare companies, focusing on therapeutics. Doug Zingale is the Managing Partner of Blue Goose Capital. The firm was founded in 2018 and is based in Cambridge, MA.